A new study shows that two drugs can block the death of brain cells in mice. Dr Doug Brown, Director of Research and Development at Alzheimer’s Society, comments.
From the May 2015 issue of our magazine, a different looking dementia medication can cause confusion even though it has the right active ingredient. Fiona Madden speaks to a carer whose husband insists on a specific brand.
A Vancouver-based research team led by Dr Patrick McGeer, has published a paper suggesting that anti-inflammatory drugs could prevent Alzheimer’s disease.
The Advertising Standards Agency (ASA) have upheld a complaint made against Neuronix for their advertising of a medical device in relation to Alzheimer's disease.
Carers share advice on sudden changes in how someone’s dementia is progressing.
Carers share advice on sudden changes in how someone’s dementia is progressing.
...
Pfizer has announced that it will be ending its neuroscience discovery and early development efforts, an area which includes research into drug development for Alzheimer’s disease.
Dementia Support Line